In summary, our results demonstrated that AMS is accompanied by changes in lung function parameters, increased plasma tryptophan and serotonin levels, and that the EDN1 polymorphism is a potential risk factor for AMS. This evidence concerns the gene EDN1 and ablepharon macrostomia syndrome.